Your Notifications
All done, no notifications

What is Chronic Lymphocytic Leukemia (CLL)?

Chronic lymphocytic leukemia (CLL) is a type of blood cancer in which abnormal lymphocytes, most commonly B lymphocytes, accumulate in the blood, bone marrow, lymph nodes, and spleen. CLL usually develops slowly and may not cause symptoms early on.

The disease can affect the normal production and function of blood cells, potentially leading to anemia, increased susceptibility to infections, or low platelet counts. CLL is closely related to small lymphocytic lymphoma (SLL), with the distinction primarily based on where the abnormal lymphocytes are found.

What is the Importance of Timely Treatment?

A timely diagnosis helps determine the extent and biological characteristics of CLL and whether treatment is needed. Not every person diagnosed with CLL needs immediate treatment. Patients without symptoms or with stable disease may be managed with active surveillance, including regular blood tests and clinical assessments.

What are the Common Symptoms of Chronic Lymphocytic Leukemia (CLL)?

  • Persistent fatigue or weakness
  • Painless swelling of lymph nodes in the neck, armpits, or groin
  • Frequent or recurrent infections
  • Unexplained weight loss
  • Fever without an obvious infection
  • Drenching night sweats
  • Easy bruising or bleeding
  • Shortness of breath related to anemia
  • Abdominal fullness or discomfort due to an enlarged spleen

Causes and Risk Factors of Chronic Lymphocytic Leukemia (CLL)

Causes

  • The exact cause of CLL is not known. The disease develops when genetic and molecular changes cause abnormal B lymphocytes to survive and accumulate. These abnormal cells can gradually build up in the blood, bone marrow, lymph nodes, and spleen.

Risk Factors

  • Increasing age
  • Male sex
  • Having a first-degree relative with CLL or another related lymphoid cancer
  • Certain inherited genetic susceptibility factors
  • Being of European ancestry, as CLL occurs less frequently in some other populations

Latest Research and Technologies in the Treatment of Chronic Lymphocytic Leukemia (CLL) in India

CLL treatment has advanced with targeted therapies and molecular risk assessment, including BTK inhibitors and the BCL2 inhibitor venetoclax, which may be combined with anti-CD20 antibodies. Genetic and molecular testing, including TP53 abnormalities and IGHV mutation status, helps guide treatment selection, while newer options such as the non-covalent BTK inhibitor pirtobrutinib and cellular therapies expand treatment options for selected patients with relapsed or refractory CLL.

Treatment options for Chronic Lymphocytic Leukemia (CLL)

Active surveillance: Patients with early or asymptomatic CLL may be monitored regularly without immediate treatment.

Combination therapy: Targeted medicines may be combined with antibodies or other agents depending on the patient's disease characteristics.

Chemotherapy : Traditional chemotherapy has a more limited role than in the past but may still be considered in specific circumstances.

Cost Start From 300Explore Options

CAR-T Cell Therapy : It is specifically approved as a highly effective option for adults with relapsed or refractory CLL who have already exhausted standard BTK and BCL-2 inhibitor treatments.

Cost Start From 80000Explore Options

Stem cell transplantation : Allogeneic stem cell transplantation may be considered for a small number of carefully selected patients with high-risk, treatment-resistant disease.

Cost Start From 11500Explore Options

  • Clinical assessment:
    • Complete blood count (CBC): Identifies lymphocytosis and evaluates red blood cells and platelets.
    • Peripheral blood smear: Helps assess the appearance of circulating lymphocytes.
    • Flow cytometry: Identifies the characteristic immunophenotype of CLL cells and helps confirm the diagnosis.
    • Biochemical tests: Kidney and liver function tests and other blood investigations may be performed to assess overall health and treatment readiness.
    • Genetic and molecular tests: FISH, TP53 testing, IGHV mutation status, and other molecular investigations can provide prognostic and treatment-related information.
  • Imaging Tests:
    • CT scan: May evaluate enlarged lymph nodes, spleen, or other areas when clinically indicated.
    • PET/CT: Is not routinely required for uncomplicated CLL but can be useful when transformation to a more aggressive lymphoma is suspected.
    • Ultrasound: May be used to assess the spleen, liver, or accessible lymph nodes in selected situations.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support Chronic Lymphocytic Leukemia (CLL) patients in India. These services include:

  • Physical activity: Appropriate activity can help maintain muscle strength, mobility, and endurance.
  • Physiotherapy: May help with weakness, reduced mobility, or treatment-related physical limitations.
  • Nutritional support: Helps maintain adequate nutrition during treatment and recovery.
  • Fatigue management: Energy conservation, sleep support, gradual activity, and appropriate rest may help manage cancer-related fatigue.
  • Psychological support: Counselling and supportive-care services can help patients cope with the emotional and social effects of living with CLL.
  • Medicines for CLL primarily target abnormal lymphocytes and the pathways that allow them to survive. Commonly used treatments include BTK inhibitors. Anti-CD20 monoclonal antibodies. Newer medicines, including non-covalent BTK inhibitors such as pirtobrutinib, may be considered in certain relapsed or treatment-resistant cases. Supportive medicines may also be used to manage infections, anemia, treatment-related side effects, or other complications.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Chronic Lymphocytic Leukemia (CLL) in India

RATHIMED SPECIALITY HOSPITAL: Top Doctors, and Reviews
RATHIMED SPECIALITY HOSPITAL

Chennai, India

  • Rathi Med Hospital possesses a great reputation as a centre for orthopaedics and reconstructive surgery for fractures of the knee, hip, spinal column and shoulder. It provides advanced methods for the treatment of various conditions of the knee such as arthritis, sports injuries, and other injuries related to joints, as well as other related conditions that affect mobility. The hospital has developed a unique treatment approach for knee preservation known as the KPA Knee Preservation 36? Approach. In the area of obstetrics and gynaecology, the hospital offers services related to painless delivery, cesarean birth, postnatal care, fertility care and overall wellness for women.
Message Us

59

PROCEDURE

2

DOCTORS IN 12 SPECIALITIES

18+

FACILITIES & AMENITIES

SSO Cancer Hospital, Mumbai: Top Doctors, and Reviews
SSO Cancer Hospital, Mumbai

Mumbai, India

  • SSO is a hospital that provides surgical oncology care tailored to each organ and employs experienced surgeons who work exclusively in this field. SSO has designed its surgical program to include minimally invasive techniques such as laparoscopic and robotic-assisted methods. Furthermore, SSO provides individualised treatment planning for cancers and has created a multidisciplinary team to provide comprehensive care to each cancer patient throughout the treatment process. In addition to providing an excellent surgical experience, SSO's aim is to help each patient retain as much functioning ability and aesthetic appearance post-surgery as possible. Lastly, SSO provides extensive support services, including physiotherapy, nutritional counselling, rehabilitation, and post-operative care.
Message Us

18

PROCEDURE

9

DOCTORS IN 1 SPECIALITIES

18+

FACILITIES & AMENITIES

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose India for Chronic Lymphocytic Leukemia (CLL) Treatment?

  • Experienced hematologists: Specialists with expertise in leukemia diagnosis, risk assessment, targeted therapy, and long-term disease management.
  • Advanced diagnostic facilities: Flow cytometry, cytogenetic testing, FISH, molecular testing, and advanced imaging can support diagnosis and treatment planning.
  • Modern targeted therapies: Eligible patients may have access to BTK inhibitors, BCL2 inhibitors, monoclonal antibodies, and newer treatment approaches.
  • Multidisciplinary care: Hematologists, oncologists, pathologists, radiologists, transplant specialists, and supportive-care teams can collaborate on complex cases.
  • International patient support: Many major hospitals provide dedicated services for international patients, including treatment coordination, documentation, accommodation, travel assistance, and follow-up planning.

Frequently Asked Questions

There is no fixed recovery period for CLL because it is often a long-term condition that may be monitored or treated over different periods. Recovery from active treatment depends on the therapy used, disease response, side effects, and the patient's overall health.

Yes. Most people with CLL can walk and remain physically active if their health permits. Activity may need to be adjusted during periods of significant fatigue, anemia, infection, low blood counts, or treatment-related side effects.

Many specialised Indian cancer centres provide advanced diagnostic facilities such as flow cytometry, FISH and molecular testing, along with modern targeted therapies for eligible CLL patients. Availability varies by hospital and individual clinical circumstances.

Many major Indian hospitals have international patient departments that assist with medical appointments, treatment coordination, travel documentation, accommodation, interpretation, and follow-up arrangements.

Look for a centre with experienced hematologists, specialised leukemia services, advanced flow cytometry and molecular diagnostics, access to targeted therapies, and multidisciplinary care. For complex or relapsed CLL, consider whether the centre offers advanced treatment options and transplant or cellular-therapy services when clinically appropriate.

There is no single success rate for CLL. Outcomes vary according to age, disease stage, genetic and molecular characteristics, overall health, previous treatments, and response to therapy. Many patients can achieve prolonged disease control with modern treatment, but CLL may require long-term monitoring.

India has specialised hematology and oncology centres with experience in diagnosing and treating leukemia, including CLL. Patients should consider the specialist's experience with CLL and the hospital's available diagnostic, treatment, transplant, and supportive-care facilities.

Risks vary by treatment. Targeted medicines can cause treatment-specific effects such as infections, bleeding, heart-rhythm problems, high blood pressure, or tumour lysis syndrome. Immunotherapy can cause infusion or immune-related reactions, while chemotherapy can cause low blood counts, infections, nausea, and fatigue. Your doctor will assess individual risks before treatment.

After diagnosis, consult a hematologist to confirm the diagnosis and assess the disease's stage and biological characteristics. Ask about blood test results, genetic and molecular findings, whether treatment is required immediately, available treatment options, and the recommended monitoring schedule.

CLL does not typically cause permanent physical deformities. However, advanced disease or treatment-related complications can sometimes affect physical function or general health.

Yes. Fatigue, recurrent infections, enlarged lymph nodes, treatment side effects, emotional stress, and concerns about long-term disease management can affect quality of life. Physical activity, nutritional care, symptom management, and psychological support can help address these challenges.

Some people with early or asymptomatic CLL can remain stable for years without treatment and may be safely monitored through active surveillance. However, progressive CLL can cause worsening blood counts, enlarged lymph nodes or spleen, recurrent infections, and other complications. In some patients, CLL can transform into a more aggressive lymphoma.

There is no established way to completely prevent CLL because its exact cause is not known. Some risk factors, such as age and inherited susceptibility, cannot be changed. Maintaining overall health and discussing persistent or unexplained symptoms with a healthcare professional can support general well-being but cannot guarantee prevention.

Yes. CLL is more common in older adults and occurs more frequently in men than women. It is also more common among people of European ancestry than in some other populations. Having a close relative with CLL or a related lymphoid cancer can also increase risk.